Bonemass D Tablet

About Bonemass D 70 mg+2800 IU Tablet

Bonemass D 70 mg+2800 IU tablet is a medicine made by Incepta Pharmaceuticals Ltd. It helps increase bone mass and reduces the incidence of fractures, including fractures of the hip and spine.

There are 4 brands of Alendronic Acid + Vitamin D3 listed in Bangladesh. By unit price, Bonemass D is among the cheapest of them.

What is Bonemass D 70 mg+2800 IU Tablet?

Bonemass D comes as a tablet with 70 mg+2800 IU of Alendronic Acid + Vitamin D3, from Incepta Pharmaceuticals Ltd. It is used to treat osteoporosis in postmenopausal women and in men, helping to increase bone mass and reduce the chance of fractures, including those of the hip and spine. Alendronic acid works by slowing the activity of cells that break down bone. Ask your doctor or pharmacist if you are unsure about it.

Uses of Bonemass D

It helps increase bone mass and reduces the incidence of fractures, including fractures of the hip and spine. It is a combined preparation that inhibits bone resorption. Do not start, stop or change treatment without medical advice. Your doctor will decide if it is suitable for you.

How to use Bonemass D

Swallow the tablet with water as advised by your doctor or pharmacist. Bonemass D is taken by mouth. If a dose is missed, ask the doctor or pharmacist what to do. Ask your doctor or pharmacist for the correct way to take it. Do not change the dose or stop early without asking your doctor.

Side effects of Bonemass D

Side effects are usually mild and generally do not require stopping therapy. Stop taking the medicine and consult your doctor if you develop esophageal problems. Tell your doctor if any side effect bothers you or does not go away.

Safety and precautions

Cholecalciferol passes into breast milk, and it is not known whether alendronate is excreted in human milk, so caution is needed during breastfeeding. The medicine is pregnancy category C; it should be used in pregnancy only if the potential benefit justifies the potential risk to the mother and fetus. Alendronate can irritate the upper gastrointestinal mucosa, so caution is needed if you have active upper gastrointestinal problems such as difficulty swallowing, esophageal disease, gastritis, duodenitis or ulcers. Tell your doctor about all the other medicines you take.

Frequently asked questions

Why is Bonemass D prescribed?

It helps increase bone mass and reduces the incidence of fractures, including fractures of the hip and spine. It is a combined preparation that inhibits bone resorption.

How do I use Bonemass D correctly?

Swallow the tablet with water as advised by your doctor or pharmacist. Bonemass D is taken by mouth.

What should I watch for while using Bonemass D?

Side effects are usually mild and generally do not require stopping therapy. Stop taking the medicine and consult your doctor if you develop esophageal problems.

How much does Bonemass D cost in Bangladesh?

The listed price is ৳ 30.00.

Indications

Alendronic Acid & Vitamin D3 is indicated in:
  • Treatment of osteoporosis in postmenopausal women.
  • Treatment of osteoporosis in men.
  • Treatment of osteoporosis as it increases the bone mass and reduces the incidence of fractures, including those of the hip and spine.

Pharmacology

Alendronate Sodium is a bisphosphonate that acts as a specific inhibitor of osteoclast mediated bone resorption. Alendronate is effective when administered at least 30 minutes before breakfast. It transiently distributes to soft tissues following administration but is then rapidly distributed to bone or excreted in the urine. Protein binding in human plasma is approximately 78%. There is no evidence that Alendronate is metabolised in animals or humans. At the cellular level, Alendronate shows preferential localization to sites of bone resorption, specially under osteoclasts. It inhibits osteoclast activity. In addition, bone formation exceeds bone resorption, leading to progressive gains in bone mass. Vitamin D is required for normal bone formation. Vitamin D insufficiency develops when both sunlight exposure and dietary intake are inadequate. Insufficiency is associated with negative calcium balance, increased parathyroid hormone levels, bone loss, and increased risk of skeletal fracture.

Dosage & Administration

Treatment of Osteoporosis in Postmenopausal Women: The recommended dosage is-
  • 70 mg alendronate and 2800 IU vitamin D3 or
  • 70 mg alendronate and 5600 IU vitamin D3 tablet once weekly.
  • For most osteoporotic women, the appropriate dose is 70 mg alendronate and 5600 IU vitamin D3 once weekly.
Treatment to Increase Bone Mass in Men with Osteoporosis: The recommended dosage is-
  • 70 mg alendronate and 2800 IU vitamin D3 or
  • 70 mg alendronate and 5600 IU D3 tablet once weekly.
  • For most osteoporotic men, the appropriate dose is 70 mg alendronate and 5600 IU vitamin D3 once weekly.

Interaction

Calcium supplement, antacids and some oral medications will interfere with absorption of Alendronate if taken at the same time. Intravenous ranitidine makes the bioavailability of oral Alendronate double. Incidence of upper gastro-intestinal adverse events associated with NSAID and aspirin appears to be greater with concomitant administration of Alendronate. Mineral oils, orlistat, and bile acid sequestrants (e.g., cholestyramine, colestipol) may impair the absorption of vitamin D. Anticonvulsants, cimetidine, and thiazides may increase the catabolism of vitamin D.

Contraindications

  • Abnormalities of the esophagus which delay esophageal emptying, such as stricture or achalasia.
  • Inability to stand or sit upright for at least 30 minutes.
  • Hypersensitivity to any component of this product.
  • Hypocalcaemia.

Side Effects

Usually mild and generally do not require discontinuation of therapy. Side effects include esophageal reactions, abdominal pain and distension, diarrhoea or constipation, flatulence, musculoskeletal pain, headache, rash, erythema and transient decreases in serum calcium and phosphate.

Pregnancy & Lactation

Pregnancy category C. Overdoses of vitamin D have shown teratogenic effects in pregnant animals. Alendronic Acid & Vitamin D3 (Colecalciferol) should be used during pregnancy only if the potential benefit justifies the potential risk to the mother and fetus. Cholecalciferol and some of its active metabolites pass into breast milk. It is not known whether alendronate is excreted in human milk. Caution should be exercised when administered to lactating women.

Precautions & Warnings

Hypocalcaemia and other disturbances of mineral metabolism should be corrected before initiation of therapy. Alendronate can cause local irritation of the upper gastro-intestinal mucosa. Caution should be used when Alendronate is given to patients with active upper gastrointestinal problems such as dysphagia, esophageal disease, gastritis, duodenitis or ulcers. Patients should stop taking medicine and consult their physician if they develop esophageal diseases.

Overdose Effects

Hypocalcemia, hypophosphatemia, and upper gastrointestinal adverse events, such as upset stomach, heartburn, esophagitis, gastritis, or ulcer, may result from oral overdosage.  Signs and symptoms of vitamin D toxicity include hypercalcemia, hypercalciuria, anorexia, nausea, vomiting, polyuria, polydipsia, weakness, and lethargy.

Storage Conditions

Store in a cool and dry place. Protect from light & moisture. Keep out of the reach of children.

Alternative brands of Alendronic Acid + Vitamin D3

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.